![]() |
AstraZeneca says U.S. trial data shows 79% efficacy against symptomatic COVID-19
AstraZeneca's COVID-19 vaccine provided strong protection against disease and complete protection against hospitalization and death across all age groups in a late-stage U.S. study, the company announced Monday.More... From http://start.westnet.ca News News Provided By WestNet Wireless Internet |
| All times are GMT. The time now is 08:00 AM. |